115 related articles for article (PubMed ID: 7820067)
1. The release of acetylcholinesterase in vivo is regulated by dopaminergic systems in the guinea-pig substantia nigra.
Dally JJ; Greenfield SA
Neurochem Int; 1994 Oct; 25(4):339-44. PubMed ID: 7820067
[TBL] [Abstract][Full Text] [Related]
2. The spontaneous release of acetylcholinesterase in rat substantia nigra is altered by local changes in extracellular levels of dopamine.
Dally JJ; Schaefer M; Greenfield SA
Neurochem Int; 1996 Dec; 29(6):629-35. PubMed ID: 9113130
[TBL] [Abstract][Full Text] [Related]
3. Blockade of dopamine storage, but not of dopamine synthesis, prevents activation of a tolbutamide-sensitive K+ channel in the guinea-pig substantia nigra.
McGroarty A; Greenfield SA
Exp Brain Res; 1996 Aug; 110(3):360-6. PubMed ID: 8871095
[TBL] [Abstract][Full Text] [Related]
4. Raphé nucleus-evoked release of acetylcholinesterase from guinea-pig substantia nigra.
Dickie BG; Greenfield SA
Neuroreport; 1994 Mar; 5(7):769-72. PubMed ID: 8018847
[TBL] [Abstract][Full Text] [Related]
5. Differential release of acetylcholinesterase in vivo, from the guinea pig substantia nigra compared to the caudate putamen following dopamine depletion.
Dally JJ; Temlett JA; Greenfield SA
Neuropharmacology; 1996 May; 35(5):579-87. PubMed ID: 8887965
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the dopaminergic neurotransmission with AMPT and reserpine induces a differential expression of genes of the dopaminergic phenotype in substantia nigra.
Ortiz-Padilla S; Soto-Orduño E; Barrios ME; Manjarrez AA; Bastián Y; Mendez JA
Neuropharmacology; 2020 Apr; 166():107920. PubMed ID: 31870855
[TBL] [Abstract][Full Text] [Related]
7. Release of acetylcholinesterase from guinea-pig substantia nigra: effects of tryptaminergic drugs and dorsal raphé nucleus stimulation.
Dickie BG; Greenfield SA
Neuropharmacology; 1995 Sep; 34(9):1191-200. PubMed ID: 8532190
[TBL] [Abstract][Full Text] [Related]
8. Endogenous dopamine modifies electroresponsiveness of pars compacta cells in the guinea pig substantia nigra in vitro.
Kapoor R; Webb C; Greenfield SA
Exp Brain Res; 1989; 74(3):653-7. PubMed ID: 2707341
[TBL] [Abstract][Full Text] [Related]
9. Effects of glutamate antagonists on nigral dopamine release in the reserpine-treated rat.
Biggs C; Starr M; Fowler L; Whitton P
Biochem Soc Trans; 1996 Feb; 24(1):173-7. PubMed ID: 8674654
[No Abstract] [Full Text] [Related]
10. Release of acetylcholinesterase within the guinea-pig substantia nigra: effects of 5-hydroxytryptamine and amphetamine.
Taylor SJ; Bartlett MJ; Greenfield SA
Neuropharmacology; 1988 May; 27(5):507-14. PubMed ID: 3260662
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.
Biggs CS; Fowler LJ; Whitton PS; Starr MS
Eur J Pharmacol; 1996 Mar; 299(1-3):83-91. PubMed ID: 8901010
[TBL] [Abstract][Full Text] [Related]
12. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
Greenfield SA; Grünewald RA; Foley P; Shaw SG
J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural localization of acetylcholinesterase in substantia nigra: a comparison between rat and guinea pig.
Henderson Z; Greenfield SA
J Comp Neurol; 1984 Dec; 230(2):278-86. PubMed ID: 6512022
[TBL] [Abstract][Full Text] [Related]
14. The relationship between visual stimulation, behaviour and continuous release of protein in the substantia nigra.
Jones SA; Ellis JR; Klegeris A; Greenfield SA
Brain Res; 1991 Sep; 560(1-2):163-6. PubMed ID: 1760724
[TBL] [Abstract][Full Text] [Related]
15. "On-line" measurement of acetylcholinesterase release from the substantia nigra of the freely-moving guinea-pig.
Taylor SJ; Jones SA; Haggblad J; Greenfield SA
Neuroscience; 1990; 37(1):71-6. PubMed ID: 2243598
[TBL] [Abstract][Full Text] [Related]
16. The subthalamo-nigral pathway regulates movement and concomitant acetylcholinesterase release from the substantia nigra.
Jones SA; Dickie BG; Klegeris A; Greenfield SA
J Neural Transm Gen Sect; 1994; 98(1):23-37. PubMed ID: 7536013
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
Heeringa MJ; Abercrombie ED
J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
[TBL] [Abstract][Full Text] [Related]
18. Differential actions of acetylcholinesterase on the soma and dendrites of dopaminergic substantia nigra neurons in vitro.
Hajós M; Greenfield S
Brain Res; 1992 Jul; 585(1-2):416-20. PubMed ID: 1511329
[TBL] [Abstract][Full Text] [Related]
19. Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices.
Elverfors A; Jonason J; Jonason G; Nissbrandt H
Synapse; 1997 Aug; 26(4):359-69. PubMed ID: 9215595
[TBL] [Abstract][Full Text] [Related]
20. An electrophysiological action of acetylcholinesterase independent of its catalytic site.
Greenfield SA; Jack JJ; Last AT; French M
Exp Brain Res; 1988; 70(2):441-4. PubMed ID: 3384044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
